TapewireFind a company

person · Reporting owner

Andrle Edward

Disclosed activity across 2 companies

Tapewire entity
53404
SEC CIK
0001656026

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
NEUROONE MEDICAL TECHNOLOGIES CorpNMTC · Entity 7808DirectorApril 03, 2026April 07, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

NEUROONE MEDICAL TECHNOLOGIES Corp

Report date April 03, 2026 · Filed April 07, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect133,932 Reported balance After 2026-04-03 transaction · row 1
1 source row

Row 1 · 2026-04-03 · Grant · Acquired 41,929 · Balance 133,932

F1: Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.

Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.80 · Expires 2036-04-02Direct26,036 Reported balance After 2026-04-03 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2026-04-03 · Grant · Acquired 26,036 · Balance 26,036

F2: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.

Filing footnotes · ownership attribution and instrument terms

F1: Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.

F2: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

LivaNova PLC

Report date January 01, 2020 · Filed January 07, 2020

Section 16 reporting ended · disclosed 2020-01-07. Current position is not established by this disclosure.

No balance rows disclosed in this filing.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
April 03, 2026 Filed Apr 7, 2026 17:22 UTC NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 GrantOption to Purchase Common Stock · Derivative 26,036 $0.00 Strike: $0.80 $0.00
Disclosure

SEC source: 0001656026-26-000003 · primary_doc.xml · derivative · entry 2

Andrle Edward · CIK 0001656026 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,036

Underlying: Common Stock · 26,036 shares

Expires 2036-04-02

F2 · derivative.exercise_date: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.

Read SEC document
April 03, 2026 Filed Apr 7, 2026 17:22 UTC NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 GrantCommon Stock 41,929 $0.00 $0.00
Disclosure

SEC source: 0001656026-26-000003 · primary_doc.xml · nonDerivative · entry 1

Andrle Edward · CIK 0001656026 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,932

F1 · shares: Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.

Read SEC document
June 23, 2025 Filed Jun 25, 2025 19:34 UTC NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 GrantOption to Purchase Common Stock · Derivative 50,000 $0.00 Strike: $0.66 $0.00
Disclosure

SEC source: 0001656026-25-000002 · primary_doc.xml · derivative · entry 1

Andrle Edward · CIK 0001656026 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2035-06-23

F1 · derivative.exercise_date: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.

Read SEC document
February 14, 2025 Filed Feb 19, 2025 17:06 UTC NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 GrantOption to Purchase Common Stock · Derivative 17,025 $0.00 Strike: $1.20 $0.00
Disclosure

SEC source: 0001656026-25-000001 · primary_doc.xml · derivative · entry 2

Andrle Edward · CIK 0001656026 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,025

Underlying: Common Stock · 17,025 shares

Expires 2035-02-14

F2 · derivative.exercise_date: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.

Read SEC document
February 14, 2025 Filed Feb 19, 2025 17:06 UTC NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 GrantCommon Stock 27,778 $0.00 $0.00
Disclosure

SEC source: 0001656026-25-000001 · primary_doc.xml · nonDerivative · entry 1

Andrle Edward · CIK 0001656026 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,003

F1 · shares: Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.

Read SEC document
March 16, 2023 Filed Mar 20, 2023 17:39 UTC NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 GrantOption to Purchase Common Stock · Derivative 18,927 $0.00 Strike: $1.62 $0.00
Disclosure

SEC source: 0001656026-23-000001 · primary_doc.xml · derivative · entry 2

Andrle Edward · CIK 0001656026 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,927

Underlying: Common Stock · 18,927 shares

Expires 2033-03-16

F2 · derivative.exercise_date: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.

Read SEC document
March 16, 2023 Filed Mar 20, 2023 17:39 UTC NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 GrantCommon Stock 20,576 $0.00 $0.00
Disclosure

SEC source: 0001656026-23-000001 · primary_doc.xml · nonDerivative · entry 1

Andrle Edward · CIK 0001656026 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,225

F1 · shares: Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.

Read SEC document
May 31, 2022 Filed Jun 2, 2022 20:02 UTC NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 GrantOption to Purchase Common Stock · Derivative 29,230 $0.00 Strike: $1.14 $0.00
Disclosure

SEC source: 0001656026-22-000001 · primary_doc.xml · derivative · entry 2

Andrle Edward · CIK 0001656026 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,230

Underlying: Common Stock · 29,230 shares

Expires 2032-05-31

F2 · derivative.exercise_date: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.

Read SEC document
May 31, 2022 Filed Jun 2, 2022 20:02 UTC NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 GrantCommon Stock 29,240 $0.00 $0.00
Disclosure

SEC source: 0001656026-22-000001 · primary_doc.xml · nonDerivative · entry 1

Andrle Edward · CIK 0001656026 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,649

F1 · shares: Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.

Read SEC document
June 02, 2021 Filed Jun 4, 2021 20:06 UTC NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 GrantOption to Purchase Common Stock · Derivative 4,682 $0.00 Strike: $7.26 $0.00
Disclosure

SEC source: 0001596771-21-000037 · primary_doc.xml · derivative · entry 2

Andrle Edward · CIK 0001656026 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,682

Underlying: Common Stock · 4,682 shares

Expires 2031-06-02

F3 · derivative.exercise_date: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.

Read SEC document
June 02, 2021 Filed Jun 4, 2021 20:06 UTC NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 GrantCommon Stock 4,592 $0.00 $0.00
Disclosure

SEC source: 0001596771-21-000037 · primary_doc.xml · nonDerivative · entry 1

Andrle Edward · CIK 0001656026 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,404

F1 · shares: Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.

F2 · balance_after: The share amount has been adjusted to reflect the reverse stock split effective on March 31, 2021 whereby each three shares of common stock issued and outstanding prior to the split were combined and converted into one share of common stock.

Read SEC document
June 02, 2020 Filed Jun 4, 2020 21:07 UTC NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 GrantOption to Purchase Common Stock · Derivative 23,725 $0.00 Strike: $1.48 $0.00
Disclosure

SEC source: 0001596771-20-000045 · primary_doc.xml · derivative · entry 2

Andrle Edward · CIK 0001656026 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,725

Underlying: Common Stock · 23,725 shares

Expires 2030-06-02

F2 · derivative.exercise_date: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.

Read SEC document
June 02, 2020 Filed Jun 4, 2020 21:07 UTC NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 GrantCommon Stock 22,371 $0.00 $0.00
Disclosure

SEC source: 0001596771-20-000045 · primary_doc.xml · nonDerivative · entry 1

Andrle Edward · CIK 0001656026 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,435

F1 · shares: Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.

Read SEC document
February 19, 2020 Filed Feb 21, 2020 21:55 UTC NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 GrantCommon Stock 7,064 $0.00 $0.00
Disclosure

SEC source: 0001596771-20-000008 · primary_doc.xml · nonDerivative · entry 1

Andrle Edward · CIK 0001656026 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,064

F1 · shares: Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.

Read SEC document
October 18, 2019 Filed Oct 31, 2019 15:17 UTC LivaNova PLC LIVN · Entity 507 Exercise / conversionStock Appreciation Rights · Derivative 29,718 $0.00 Strike: $69.39 $0.00
Disclosure

SEC source: 0001639691-19-000146 · wf-form4_157253501542050.xml · derivative · entry 2

Andrle Edward · CIK 0001656026 · General Manager, NM

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,513

Underlying: Ordinary Shares · 29,718 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Reporting person was granted an award of stock appreciation rights ("SARs"). Subject to the terms and conditions of the LivaNova PLC 2015 Incentive Award Plan (the "Plan") and the SAR Agreement, the SARs shall vest in equal installments of 25% on each of the four anniversaries of the grant date, October 19, 2015.

F1 · derivative.expiration_date: Reporting person was granted an award of stock appreciation rights ("SARs"). Subject to the terms and conditions of the LivaNova PLC 2015 Incentive Award Plan (the "Plan") and the SAR Agreement, the SARs shall vest in equal installments of 25% on each of the four anniversaries of the grant date, October 19, 2015.

Read SEC document
October 18, 2019 Filed Oct 31, 2019 15:17 UTC LivaNova PLC LIVN · Entity 507 Exercise / conversionOrdinary Shares 29,718 $69.39 $2,062,132.02
Disclosure

SEC source: 0001639691-19-000146 · wf-form4_157253501542050.xml · nonDerivative · entry 1

Andrle Edward · CIK 0001656026 · General Manager, NM

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,502

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 18, 2019 Filed Nov 1, 2019 20:58 UTC Amendment LivaNova PLC LIVN · Entity 507 Exercise / conversionStock Appreciation Rights · Derivative 29,718 $0.00 Strike: $69.39 $0.00
Disclosure

SEC source: 0001639691-19-000147 · wf-form4a_157264189263445.xml · derivative · entry 3

Andrle Edward · CIK 0001656026 · General Manager, NM

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,513

Underlying: Ordinary Shares · 29,718 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Reporting person was granted an award of SARs. Subject to the terms and conditions of the the Plan and the SAR Agreement, the SARs shall vest on the anniversary of the grant date, October 19, 2015.

F2 · derivative.expiration_date: Reporting person was granted an award of SARs. Subject to the terms and conditions of the the Plan and the SAR Agreement, the SARs shall vest on the anniversary of the grant date, October 19, 2015.

Read SEC document
October 18, 2019 Filed Nov 1, 2019 20:58 UTC Amendment LivaNova PLC LIVN · Entity 507 Tax withholdingOrdinary Shares 28,447 $74.66 $2,123,853.02
Disclosure

SEC source: 0001639691-19-000147 · wf-form4a_157264189263445.xml · nonDerivative · entry 2

Andrle Edward · CIK 0001656026 · General Manager, NM

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,055

F1 · shares: Form 4 amended to show cashless exercise by the LivaNova PLC (the "Company") pursuant to the LivaNova PLC 2015 Incentive Award Plan (the "Plan") on the last business day prior to expiration of the stock appreciation rights ("SARs") whereby 28,447 shares were withheld from distribution to cover the purchase of shares and to satisfy tax liability.

Read SEC document
October 18, 2019 Filed Nov 1, 2019 20:58 UTC Amendment LivaNova PLC LIVN · Entity 507 Exercise / conversionOrdinary Shares 29,718 $69.39 $2,062,132.02
Disclosure

SEC source: 0001639691-19-000147 · wf-form4a_157264189263445.xml · nonDerivative · entry 1

Andrle Edward · CIK 0001656026 · General Manager, NM

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,502

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 28, 2019 Filed Jul 2, 2019 20:42 UTC LivaNova PLC LIVN · Entity 507 GrantOrdinary Shares 273 $61.17 $16,699.41
Disclosure

SEC source: 0001639691-19-000113 · wf-form4_156210014104377.xml · nonDerivative · entry 1

Andrle Edward · CIK 0001656026 · General Manager, NM

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,784

F1 · kind: These shares were acquired under the LivaNova Employee Stock Purchase Plan that are exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
May 05, 2019 Filed May 7, 2019 19:31 UTC LivaNova PLC LIVN · Entity 507 Exercise / conversionRestricted Stock Units · Derivative 688 $0.00 $0.00
Disclosure

SEC source: 0001639691-19-000074 · wf-form4_155725747879296.xml · derivative · entry 3

Andrle Edward · CIK 0001656026 · General Manager, NM

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,534

Underlying: Ordinary Shares · 688 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive Ordinary Share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the Plan) and the award agreement.

F4 · derivative.exercise_date: Reporting person was granted RSUs subject to a four-year vesting schedule, vesting 25% on each of the first four anniversaries of May 5, 2017, subject to continued service during the vesting period.

F4 · derivative.expiration_date: Reporting person was granted RSUs subject to a four-year vesting schedule, vesting 25% on each of the first four anniversaries of May 5, 2017, subject to continued service during the vesting period.

Read SEC document
May 05, 2019 Filed May 7, 2019 19:31 UTC LivaNova PLC LIVN · Entity 507 Tax withholdingOrdinary Shares 271 $74.77 $20,262.67
Disclosure

SEC source: 0001639691-19-000074 · wf-form4_155725747879296.xml · nonDerivative · entry 2

Andrle Edward · CIK 0001656026 · General Manager, NM

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,511

F2 · shares: The referenced shares were withheld from distribution at the request of reporting person to satisfy tax liability.

Read SEC document
May 05, 2019 Filed May 7, 2019 19:31 UTC LivaNova PLC LIVN · Entity 507 Exercise / conversionOrdinary Shares 688 $0.00 $0.00
Disclosure

SEC source: 0001639691-19-000074 · wf-form4_155725747879296.xml · nonDerivative · entry 1

Andrle Edward · CIK 0001656026 · General Manager, NM

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,782

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares (Ordinary Shares) of LivaNova PLC (the Company), GBP 1.00 par value.

Read SEC document
March 29, 2019 Filed Apr 2, 2019 20:06 UTC LivaNova PLC LIVN · Entity 507 GrantStock Appreciation Rights · Derivative 5,903 $0.00 $0.00
Disclosure

SEC source: 0001639691-19-000055 · wf-form4_155423558567525.xml · derivative · entry 4

Andrle Edward · CIK 0001656026 · General Manager, NM

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,231

Underlying: Ordinary Shares · 5,903 shares

Expires not disclosed

F6 · derivative.exercise_price: 93.25 Conversion or Exercise Price of Derivative Security.

F7 · derivative.exercise_date: Reporting person was granted an award of stock appreciation rights ("SARs"). Subject to the terms and conditions of the Plan and the SAR Agreement, the SARs shall vest in equal installments of 25% on each of the first four anniversaries of the grant date, March 29, 2019.

F7 · derivative.expiration_date: Reporting person was granted an award of stock appreciation rights ("SARs"). Subject to the terms and conditions of the Plan and the SAR Agreement, the SARs shall vest in equal installments of 25% on each of the first four anniversaries of the grant date, March 29, 2019.

Read SEC document
March 29, 2019 Filed Apr 2, 2019 20:06 UTC LivaNova PLC LIVN · Entity 507 GrantPerformance Stock Units · Derivative 1,928 $0.00 $0.00
Disclosure

SEC source: 0001639691-19-000055 · wf-form4_155423558567525.xml · derivative · entry 3

Andrle Edward · CIK 0001656026 · General Manager, NM

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,222

Underlying: Ordinary Shares · 1,928 shares

Expires not disclosed

F3 · derivative.exercise_price: Each performance stock unit (PSU) represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the Plan and the award agreement.

F5 · derivative.exercise_date: On March 29, 2019, reporting person was granted 1,928 PSUs to vest or lapse on the filing of the Company's Annual Report on Form 10-K for the fiscal year ending December 31, 2021 based on how the Company's cumulative adjusted free cash flow for fiscal years 2019, 2020 and 2021 compares to a target determined by the Plan Administrator. The form of agreement for this award was filed with the Securities and Exchange Commission on April 1, 2019. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting.

F5 · derivative.expiration_date: On March 29, 2019, reporting person was granted 1,928 PSUs to vest or lapse on the filing of the Company's Annual Report on Form 10-K for the fiscal year ending December 31, 2021 based on how the Company's cumulative adjusted free cash flow for fiscal years 2019, 2020 and 2021 compares to a target determined by the Plan Administrator. The form of agreement for this award was filed with the Securities and Exchange Commission on April 1, 2019. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting.

Read SEC document
March 29, 2019 Filed Apr 2, 2019 20:06 UTC LivaNova PLC LIVN · Entity 507 GrantPerformance Stock Units · Derivative 1,928 $0.00 $0.00
Disclosure

SEC source: 0001639691-19-000055 · wf-form4_155423558567525.xml · derivative · entry 2

Andrle Edward · CIK 0001656026 · General Manager, NM

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,294

Underlying: Ordinary Shares · 1,928 shares

Expires not disclosed

F3 · derivative.exercise_price: Each performance stock unit (PSU) represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the Plan and the award agreement.

F4 · derivative.exercise_date: On March 29, 2019, reporting person was granted 1,928 PSUs to vest or lapse on the filing of the Company's Annual Report on Form 10-K for the fiscal year ending December 31, 2021 ("2021 Form 10-K") based on the rank of the Company's total shareholder return for the three-year period ending December 31, 2021 relative to the total shareholder return of a peer group of companies, as determined by the Plan Administrator. The form of agreement for this award was filed with the Securities and Exchange Commission in a Current Report on Form 8-K on April 1, 2019. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting.

F4 · derivative.expiration_date: On March 29, 2019, reporting person was granted 1,928 PSUs to vest or lapse on the filing of the Company's Annual Report on Form 10-K for the fiscal year ending December 31, 2021 ("2021 Form 10-K") based on the rank of the Company's total shareholder return for the three-year period ending December 31, 2021 relative to the total shareholder return of a peer group of companies, as determined by the Plan Administrator. The form of agreement for this award was filed with the Securities and Exchange Commission in a Current Report on Form 8-K on April 1, 2019. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting.

Read SEC document
March 29, 2019 Filed Apr 2, 2019 20:06 UTC LivaNova PLC LIVN · Entity 507 GrantRestricted Stock Units · Derivative 1,928 $0.00 $0.00
Disclosure

SEC source: 0001639691-19-000055 · wf-form4_155423558567525.xml · derivative · entry 1

Andrle Edward · CIK 0001656026 · General Manager, NM

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,366

Underlying: Ordinary Shares · 1,928 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one ordinary share (Ordinary Share) of LivaNova PLC (the Company), GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the Plan) and the award agreement.

F2 · derivative.exercise_date: Reporting person was granted RSUs subject to a four-year vesting schedule, vesting 25% on each of the first four anniversaries of March 29, 2019, subject to continued service during the vesting period and the RSU Agreement.

F2 · derivative.expiration_date: Reporting person was granted RSUs subject to a four-year vesting schedule, vesting 25% on each of the first four anniversaries of March 29, 2019, subject to continued service during the vesting period and the RSU Agreement.

Read SEC document
March 15, 2019 Filed Mar 19, 2019 21:09 UTC LivaNova PLC LIVN · Entity 507 Exercise / conversionRestricted Stock Units · Derivative 1,131 $0.00 $0.00
Disclosure

SEC source: 0001639691-19-000042 · wf-form4_155302978198243.xml · derivative · entry 6

Andrle Edward · CIK 0001656026 · General Manager, NM

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,438

Underlying: Ordinary Shares · 1,131 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share (Ordinary Share) of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the Plan) and the award agreement.

F5 · derivative.exercise_date: Reporting person was granted RSUs that vest and all forfeiture restrictions thereon shall lapse on March 15, 2019. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

F5 · derivative.expiration_date: Reporting person was granted RSUs that vest and all forfeiture restrictions thereon shall lapse on March 15, 2019. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.

Read SEC document
March 15, 2019 Filed Mar 19, 2019 21:09 UTC LivaNova PLC LIVN · Entity 507 Exercise / conversionRestricted Stock Units · Derivative 531 $0.00 $0.00
Disclosure

SEC source: 0001639691-19-000042 · wf-form4_155302978198243.xml · derivative · entry 5

Andrle Edward · CIK 0001656026 · General Manager, NM

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,569

Underlying: Ordinary Shares · 531 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share (Ordinary Share) of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the Plan) and the award agreement.

F4 · derivative.exercise_date: Reporting person was granted RSUs subject to a four-year vesting schedule, vesting 25% on each of the first four anniversaries of March 15, 2018, subject to continued service during the vesting period.

F4 · derivative.expiration_date: Reporting person was granted RSUs subject to a four-year vesting schedule, vesting 25% on each of the first four anniversaries of March 15, 2018, subject to continued service during the vesting period.

Read SEC document
March 15, 2019 Filed Mar 19, 2019 21:09 UTC LivaNova PLC LIVN · Entity 507 Tax withholdingOrdinary Shares 275 $95.84 $26,356.00
Disclosure

SEC source: 0001639691-19-000042 · wf-form4_155302978198243.xml · nonDerivative · entry 4

Andrle Edward · CIK 0001656026 · General Manager, NM

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,094

F2 · shares: The referenced shares were withheld from distribution at the request of reporting person to satisfy tax liability.

Read SEC document
March 15, 2019 Filed Mar 19, 2019 21:09 UTC LivaNova PLC LIVN · Entity 507 Exercise / conversionOrdinary Shares 1,131 $0.00 $0.00
Disclosure

SEC source: 0001639691-19-000042 · wf-form4_155302978198243.xml · nonDerivative · entry 3

Andrle Edward · CIK 0001656026 · General Manager, NM

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,369

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), GBP 1.00 par value.

Read SEC document
March 15, 2019 Filed Mar 19, 2019 21:09 UTC LivaNova PLC LIVN · Entity 507 Tax withholdingOrdinary Shares 129 $95.84 $12,363.36
Disclosure

SEC source: 0001639691-19-000042 · wf-form4_155302978198243.xml · nonDerivative · entry 2

Andrle Edward · CIK 0001656026 · General Manager, NM

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,238

F2 · shares: The referenced shares were withheld from distribution at the request of reporting person to satisfy tax liability.

Read SEC document
March 15, 2019 Filed Mar 19, 2019 21:09 UTC LivaNova PLC LIVN · Entity 507 Exercise / conversionOrdinary Shares 531 $0.00 $0.00
Disclosure

SEC source: 0001639691-19-000042 · wf-form4_155302978198243.xml · nonDerivative · entry 1

Andrle Edward · CIK 0001656026 · General Manager, NM

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,367

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), GBP 1.00 par value.

Read SEC document
March 11, 2019 Filed Mar 14, 2019 00:28 UTC LivaNova PLC LIVN · Entity 507 Exercise / conversionRestricted Stock Units · Derivative 5,208 $0.00 $0.00
Disclosure

SEC source: 0001639691-19-000028 · wf-form4_155252327157751.xml · derivative · entry 3

Andrle Edward · CIK 0001656026 · General Manager, NM

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,100

Underlying: Ordinary Shares · 5,208 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary shares (Ordinary Share) of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the Plan) and the award agreement.

F4 · derivative.exercise_date: The reporting person was granted restricted stock units subject to a four-year vesting schedule, vesting 20% on, each, March 11, 2017, March 11, 2018 and March 11, 2019, and 40% on March 11, 2020. The restricted stock units are subject to forfeiture prior to vesting in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan.

F4 · derivative.expiration_date: The reporting person was granted restricted stock units subject to a four-year vesting schedule, vesting 20% on, each, March 11, 2017, March 11, 2018 and March 11, 2019, and 40% on March 11, 2020. The restricted stock units are subject to forfeiture prior to vesting in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan.

Read SEC document
March 11, 2019 Filed Mar 14, 2019 00:28 UTC LivaNova PLC LIVN · Entity 507 Tax withholdingOrdinary Shares 1,268 $94.87 $120,295.16
Disclosure

SEC source: 0001639691-19-000028 · wf-form4_155252327157751.xml · nonDerivative · entry 2

Andrle Edward · CIK 0001656026 · General Manager, NM

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,836

F2 · shares: The referenced shares were withheld from distribution at the request of reporting person to satisfy tax liability.

Read SEC document
March 11, 2019 Filed Mar 14, 2019 00:28 UTC LivaNova PLC LIVN · Entity 507 Exercise / conversionOrdinary Shares 5,208 $0.00 $0.00
Disclosure

SEC source: 0001639691-19-000028 · wf-form4_155252327157751.xml · nonDerivative · entry 1

Andrle Edward · CIK 0001656026 · General Manager, NM

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,104

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), GBP 1.00 par value.

Read SEC document
March 01, 2019 Filed Mar 5, 2019 21:35 UTC LivaNova PLC LIVN · Entity 507 Exercise / conversionRestricted Stock Units · Derivative 2,063 $0.00 $0.00
Disclosure

SEC source: 0001639691-19-000020 · wf-form4_155182173742775.xml · derivative · entry 3

Andrle Edward · CIK 0001656026 · General Manager, NM

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,308

Underlying: Ordinary Shares · 2,063 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share (Ordinary Share) of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the Plan) and the award agreement.

F4 · derivative.exercise_date: On May 5, 2017, reporting person was granted RSUs that vest 25% on the second day after release of LivaNova's full-year 2018 financial results, February 27, 2019 (Measure Date), provided and to the extent that a market condition is achieved on the Measure Date. The market condition is a stock price that ranges between a threshold price, at which one-third of the RSUs become eligible for vesting and a target price, at which all of the RSUs become eligible for vesting, with the number of RSUs eligible for vesting at a price between the threshold price and the target price determined by linear interpolation. The number included in column 5 of Table II reflects the RSUs eligible for vesting at the target price.

F4 · derivative.expiration_date: On May 5, 2017, reporting person was granted RSUs that vest 25% on the second day after release of LivaNova's full-year 2018 financial results, February 27, 2019 (Measure Date), provided and to the extent that a market condition is achieved on the Measure Date. The market condition is a stock price that ranges between a threshold price, at which one-third of the RSUs become eligible for vesting and a target price, at which all of the RSUs become eligible for vesting, with the number of RSUs eligible for vesting at a price between the threshold price and the target price determined by linear interpolation. The number included in column 5 of Table II reflects the RSUs eligible for vesting at the target price.

Read SEC document
March 01, 2019 Filed Mar 5, 2019 21:35 UTC LivaNova PLC LIVN · Entity 507 Tax withholdingOrdinary Shares 533 $96.02 $51,178.66
Disclosure

SEC source: 0001639691-19-000020 · wf-form4_155182173742775.xml · nonDerivative · entry 2

Andrle Edward · CIK 0001656026 · General Manager, NM

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,896

F2 · shares: The referenced shares were withheld from distribution at the request of reporting person to satisfy tax liability.

Read SEC document
March 01, 2019 Filed Mar 5, 2019 21:35 UTC LivaNova PLC LIVN · Entity 507 Exercise / conversionOrdinary Shares 2,063 $0.00 $0.00
Disclosure

SEC source: 0001639691-19-000020 · wf-form4_155182173742775.xml · nonDerivative · entry 1

Andrle Edward · CIK 0001656026 · General Manager, NM

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,429

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), GBP 1.00 par value.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.